//www.prdhamaka.com/menarini-group-shares-new-analysis-from-emerald-clinical-study-of-orserdu-elacestrant-in-metastatic-breast-cancer-at-asco-2023/
Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023